May 27, 2025 04:27AM
May 21, 2025 12:42PM
May 21, 2025 06:13AM
May 21, 2025 05:13AM
May 19, 2025 08:14AM
May 12, 2025 01:36PM
May 12, 2025 06:00AM Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics
May 8, 2025 06:30AM
May 5, 2025 06:52AM
May 2, 2025 05:28PM
Mar 28, 2025 09:31AM
Mar 28, 2025 09:30AM
Mar 20, 2025 06:19AM
Jan 25, 2024 06:01AM Liquidia Technologies (LQDA) Provides Update on NDA for YUTREPIA
Jan 25, 2024 06:00AM
Jan 19, 2024 06:31AM
Jan 19, 2024 06:30AM
Jan 8, 2024 08:23AM
Jan 8, 2024 08:22AM
Jan 5, 2024 06:45AM
Jan 5, 2024 06:45AM Liquidia Provides Update on Clinical Pipeline Targeting PAH and PH-ILD
Jan 4, 2024 09:11AM
Jan 4, 2024 09:10AM
Dec 20, 2023 04:56PM
Dec 20, 2023 04:56PM
Nov 7, 2023 06:30AM
Sep 25, 2023 04:11PM
Sep 25, 2023 04:09PM FDA Accepts Submission to Add PH-ILD to YUTREPIA™ Label
Nov 3, 2021 04:55PM
Nov 3, 2021 04:55PM
Aug 18, 2021 04:15PM
Aug 18, 2021 04:15PM
Aug 12, 2021 08:02AM
Aug 12, 2021 08:00AM
Aug 12, 2021 08:00AM U.S. Patent Trial and Trademark Appeal Board Decides to Institute Inter Partes Review of United Therapeutics’ Tyvaso® Patent
Aug 10, 2021 07:00AM
Aug 10, 2021 07:00AM
Jun 2, 2021 07:00AM
Jun 2, 2021 07:00AM
Jun 2, 2021 07:00AM
Aug 10, 2020 07:15AM
Aug 10, 2020 07:15AM Liquidia Reports Second Quarter 2020 Financial Results and Provides Corporate Update
Aug 5, 2020 07:15AM
Aug 5, 2020 07:15AM
May 11, 2020 04:01PM
May 11, 2020 04:01PM
Apr 30, 2020 07:40AM
Apr 30, 2020 07:30AM
Apr 30, 2020 07:30AM Liquidia Releases Final LIQ861 Results from Pivotal Phase 3 INSPIRE Study in Patients with Pulmonary Arterial Hypertension
Apr 8, 2020 07:46AM

15,423 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All